CHENGDU., Oct. 19, 2020 – On Oct. 17 and 18, the Chengdu Science and Technology Bureau hosted the 2020 DEMO China Innovation Finals, bringing together leading companies across the country. During the award ceremony, Keya Medical was recognized as the winner of the 2020 China Health Innovation Award because of its leading R&D team and cardiovascular product line.

This award serves as a recognition of Keya Medical’s achievements throughout 2020. Earlier this year, Keya Medical became the first company in China to receive approval from the National Medical Products Administration (NMPA) an AI software medical device and has received two rounds of financing in the past six months. Despite challenges presented by the global COVID-19 pandemic, Keya Medical has positioned itself to develop new solutions that transform healthcare delivery.
Keya Medical is committed to using deep learning and advanced informatics to enable healthcare delivery organizations around the world to provide better diagnosis and treatment to patients. The company is continuing to develop AI software medical devices that can be used to transform patient care across the globe.
Keya Medical is honored to be recognized as the winner of the 2020 China Health Innovation Award. The company will continue to develop products in collaboration with healthcare organizations around the world to improve care processes and treatment outcomes.

About Keya Medical
Keya Medical Technology Co. Ltd. is a medical technology manufacturer that develops artificial intelligence applications that enable healthcare delivery organizations to provide better patient care. Since 2016, the company has combined advanced deep learning algorithms with other technologies to provide accurate diagnosis and treatment solutions to medical institutions around the world. Today, Keya Medical has partnered with over 200 healthcare systems around the world, and the company’s products are used in Chinese hospitals, coronary catheterization labs, and imaging centers. To learn more about Keya Medical, follow us on LinkedIn and Twitter.